Keywords: Benlysta, Lupus, Human Genome Sciences, GlaxoSmithKline, US rheumatologists interest

US rheumatologists express significant interest in Benlysta, the first novel drug for lupus in decades

Article | 16 June 2010

Print This

Preliminary findings indicate that, despite the availability of multiple treatment options, most of which are used in combination of three ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in